Page 2 - Wille Finance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wille finance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wille Finance Today - Breaking & Trending Today

Novartis makes investment in AI firm Yseop for clinical trial writing

Novartis makes investment in AI firm Yseop for clinical trial writing
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

France General , Emmanuel Walckenaer , Eli Lilly , Wille Finance ,

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has developed a proprietary therapy platform that uses live bacteria to deliver immune-modulating proteins to cancer . ....

Switzerland General , Michel Pairet , Simon Ittig , Boehringer Ingelheim , Engagers Tces , University Of Basel , Boehringer Ingelheim Venture Fund , Animal Health , T Cell Engagers , Managing Directors , Human Pharma , Preference Capital , Wille Finance ,

Convious | releases GPT solution

Convious has released an innovative GPT (Generative Pre-trained Transformer) customer service and support solution. ....

Camiel Kraan , Generative Pre Trained Transformer , Wille Finance , Orbit Capital ,

Convious secures Series A funding extension

Convious has received an additional $9 million of Series A funding to support the next phase of its development. ....

United Kingdom , Lukas Macko , Cyril Petit , Camiel Kraan , Orbit Capital , Wille Finance , Attraction Management System ,